An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury could be harnessed as a therapy or used as a biomarker.

Alcohol use disorders have also increased over the last decade, with an 80 percent spike among women.

A new study looks at the misconceptions, preferences and barriers keeping many ALD patients from alcohol abstinence.

A recent paper from two U-M hepatologists highlights the liver dangers associated with consuming some herbal and dietary supplements designed to build muscle or lose weight.

A month without alcohol offers a chance to examine drinking habits and recoup from the damaging effects of beer, wine and liquor. As Dry January becomes a popular trend worldwide, explore the health benefits of quitting alcohol to kick off the New Year.

A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.

Rapid rise in liver deaths highlights new challenges in treatment and prevention despite gains in fighting hepatitis C, researchers say.

After a lifetime of struggle, Edwen Lopez faced his biggest challenge: receiving a liver transplant. A Michigan Medicine transplant team was ready to help him win. 

A new review of private insurance data finds that alcohol is a major contributor to cirrhosis cases — and that women drinkers are disproportionately affected.

A Michigan Medicine researcher outlines the relationship between obesity, nonalcoholic steatohepatitis cirrhosis and a rising liver transplant burden.

It took a nearly seven-hour surgery (called a Kasai procedure), but one tiny patient avoided the need for a liver transplant in his first year of life.

Researchers are using genetics to understand nonalcoholic fatty liver disease. Learn more about fatty liver causes, NAFLD treatments, and fatty liver symptoms.

Hepatitis C testing for Baby Boomers remains low. A Michigan Medicine Specialists explain why a Hep C test is essential for this high-risk population.

University of Michigan professor finds survival rate for patients with liver disease improved with specialty care. Learn more about this paper on liver disease.

A University of Michigan physician testified before lawmakers on the pharmaceutical company Valeant’s practice of raising prices on specialized niche drugs.